{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:44:38Z","timestamp":1746341078209},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1097\/crd.0000000000000085","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T13:07:56Z","timestamp":1439557676000},"page":"177-189","source":"Crossref","is-referenced-by-count":2,"title":["Antianginal Agents for the Management of Stable Ischemic Heart Disease"],"prefix":"10.1097","volume":"24","author":[{"given":"Purav","family":"Mody","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandeep S.","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil S.","family":"Brilakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhash","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Boden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210203","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1377\/hlthaff.26.1.38","article-title":"An overview of cardiovascular disease burden in the United States.","volume":"26","author":"Mensah","year":"2007","journal-title":"Health Aff (Millwood"},{"key":"R2-5-20210203","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIR.0b013e3182456d46","article-title":"Executive summary: heart disease and stroke statistics\u20132012 update: a report from the American Heart Association.","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"R3-5-20210203","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacc.2012.03.074","article-title":"Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection.","volume":"60","author":"Celermajer","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R4-5-20210203","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/CIRCOUTCOMES.110.957175","article-title":"Recent changes in practice of elective percutaneous coronary intervention for stable angina.","volume":"4","author":"Ahmed","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R5-5-20210203","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.jacc.2013.05.099","article-title":"Cardiovascular care facts: a report from the national cardiovascular data registry: 2011.","volume":"62","author":"Masoudi","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R6-5-20210203","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/CIRCOUTCOMES.113.000282","article-title":"Changes in geographic variation in the use of percutaneous coronary intervention for stable ischemic heart disease after publication of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.","volume":"7","author":"Mohan","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R7-5-20210203","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/jamainternmed.2014.3904","article-title":"Patient selection for diagnostic coronary angiography and hospital-level percutaneous coronary intervention appropriateness: insights from the National Cardiovascular Data Registry.","volume":"174","author":"Bradley","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R8-5-20210203","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/jamainternmed.2014.164","article-title":"Fighting the \u201coculostenotic reflex\u201d.","volume":"174","author":"Lin","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R9-5-20210203","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7861\/clinmedicine.13-1-63","article-title":"Pharmacological treatment of chronic stable angina pectoris.","volume":"13","author":"Tarkin","year":"2013","journal-title":"Clin Med"},{"key":"R10-5-20210203","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1161\/CIR.0b013e3182776f83","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.","volume":"126","author":"Fihn","year":"2012","journal-title":"Circulation"},{"key":"R11-5-20210203","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease.","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"R12-5-20210203","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease.","volume":"360","author":"Frye","year":"2009","journal-title":"N Engl J Med"},{"key":"R13-5-20210203","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1056\/NEJM199201023260102","article-title":"A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME investigators.","volume":"326","author":"Parisi","year":"1992","journal-title":"N Engl J Med"},{"key":"R14-5-20210203","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199907083410202","article-title":"Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R15-5-20210203","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.CIR.0000087605.09362.0E","article-title":"Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhaus\u00e4rzte.","volume":"108","author":"Zeymer","year":"2003","journal-title":"Circulation"},{"key":"R16-5-20210203","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/CIRCINTERVENTIONS.112.000215","article-title":"Antianginal therapy before percutaneous coronary intervention.","volume":"6","author":"Borden","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"R17-5-20210203","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jacc.2007.10.063","article-title":"Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.","volume":"51","author":"Setoguchi","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R18-5-20210203","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.acvd.2011.08.001","article-title":"Update on the medical treatment of stable angina.","volume":"104","author":"Gayet","year":"2011","journal-title":"Arch Cardiovasc Dis"},{"key":"R19-5-20210203","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0002-9149(90)91033-3","article-title":"Double-blind comparison of once daily betaxolol versus propranolol four times daily in stable angina pectoris. Betaxolol Investigators Group.","volume":"65","author":"Narahara","year":"1990","journal-title":"Am J Cardiol"},{"key":"R20-5-20210203","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0002-9149(91)90518-P","article-title":"Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.","volume":"67","author":"Frishman","year":"1991","journal-title":"Am J Cardiol"},{"key":"R21-5-20210203","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/oxfordjournals.eurheartj.a014699","article-title":"The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group.","volume":"17","author":"Fox","year":"1996","journal-title":"Eur Heart J"},{"key":"R22-5-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9149(94)90483-9","article-title":"Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group.","volume":"74","author":"Thadani","year":"1994","journal-title":"Am J Cardiol"},{"key":"R23-5-20210203","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0002-8703(95)90281-3","article-title":"Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial.","volume":"129","author":"Ezekowitz","year":"1995","journal-title":"Am Heart J"},{"key":"R24-5-20210203","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0735-1097(87)80056-6","article-title":"Sustained release verapamil, a once daily preparation: objective evaluation using exercise testing, ambulatory monitoring and blood levels in patients with stable angina.","volume":"9","author":"Kohli","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"R25-5-20210203","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0002-9149(93)90292-K","article-title":"Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.","volume":"72","author":"Chrysant","year":"1993","journal-title":"Am J Cardiol"},{"key":"R26-5-20210203","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0735-1097(89)90216-7","article-title":"Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.","volume":"13","author":"DeMots","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"R27-5-20210203","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.","volume":"43","author":"Chaitman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R28-5-20210203","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"R29-5-20210203","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.jacc.2013.02.011","article-title":"Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (type 2 diabetes evaluation of ranolazine in subjects with chronic stable angina).","volume":"61","author":"Kosiborod","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R30-5-20210203","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/jama.281.20.1927","article-title":"Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.","volume":"281","author":"Heidenreich","year":"1999","journal-title":"JAMA"},{"key":"R31-5-20210203","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.jacc.2003.09.071","article-title":"Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?","volume":"43","author":"Kernis","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R32-5-20210203","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta-blockade after myocardial infarction: systematic review and meta regression analysis.","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"R33-5-20210203","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/heartjnl-2014-305719","article-title":"Prognostic impact of \u00df-blocker use in patients with stable coronary artery disease.","volume":"100","author":"Bauters","year":"2014","journal-title":"Heart"},{"key":"R34-5-20210203","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/01.CIR.90.2.762","article-title":"Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)","volume":"90","author":"Pepine","year":"1994","journal-title":"Circulation"},{"key":"R35-5-20210203","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/oxfordjournals.eurheartj.a014668","article-title":"Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group.","volume":"17","author":"Dargie","year":"1996","journal-title":"Eur Heart J"},{"key":"R36-5-20210203","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/oxfordjournals.eurheartj.a014695","article-title":"Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)","volume":"17","author":"Rehnqvist","year":"1996","journal-title":"Eur Heart J"},{"key":"R37-5-20210203","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archinte.160.7.947","article-title":"Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?","volume":"160","author":"Chen","year":"2000","journal-title":"Arch Intern Med"},{"key":"R38-5-20210203","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0735-1097(02)02013-2","article-title":"Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention.","volume":"40","author":"Chan","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R39-5-20210203","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.amjcard.2004.12.008","article-title":"Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.","volume":"95","author":"Bunch","year":"2005","journal-title":"Am J Cardiol"},{"key":"R40-5-20210203","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1741826711409325","article-title":"Long-term beta blockers for stable angina: systematic review and meta-analysis.","volume":"19","author":"Shu","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"R41-5-20210203","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"\u03b2-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"R42-5-20210203","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCOUTCOMES.114.001073","article-title":"\u03b2-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.","volume":"7","author":"Bangalore","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R43-5-20210203","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jacc.2014.04.042","article-title":"\u03b2-Blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease.","volume":"64","author":"Andersson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R44-5-20210203","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(04)16980-8","article-title":"Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial.","volume":"364","author":"Poole-Wilson","year":"2004","journal-title":"Lancet"},{"key":"R45-5-20210203","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.amjmed.2008.09.043","article-title":"Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis.","volume":"122","author":"Bangalore","year":"2009","journal-title":"Am J Med"},{"key":"R46-5-20210203","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jacc.2009.01.037","article-title":"Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.","volume":"53","author":"Wilson","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R47-5-20210203","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.jacc.2009.10.015","article-title":"2009 Focused updates: ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC\/AHA\/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"54","author":"Kushner","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R48-5-20210203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.","volume":"360","author":"Tonino","year":"2009","journal-title":"N Engl J Med"},{"key":"R49-5-20210203","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJMe068165","article-title":"Drug-eluting stents in acute myocardial infarction.","volume":"355","author":"Van de Werf","year":"2006","journal-title":"N Engl J Med"},{"key":"R50-5-20210203","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/CRD.0b013e3181c8e14a","article-title":"Nitrates and nitrites in the treatment of ischemic cardiac disease.","volume":"18","author":"Nossaman","year":"2010","journal-title":"Cardiol Rev"},{"key":"R51-5-20210203","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1056\/NEJM198706043162303","article-title":"Effect of intervals between doses on the development of tolerance to isosorbide dinitrate.","volume":"316","author":"Parker","year":"1987","journal-title":"N Engl J Med"},{"key":"R52-5-20210203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1023\/A:1007750706831","article-title":"Oral nitrates: more than symptomatic therapy in coronary artery disease?","volume":"11","author":"Thadani","year":"1997","journal-title":"Cardiovasc Drugs Ther"},{"key":"R53-5-20210203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0735-1097(95)00498-X","article-title":"Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nellInfarto Miocardico.","volume":"27","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"R54-5-20210203","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","article-title":"4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"R55-5-20210203","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.","volume":"48","author":"Stone","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R56-5-20210203","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"key":"R57-5-20210203","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N Engl J Med"},{"key":"R58-5-20210203","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jacc.2008.10.005","article-title":"ACCF\/SCAI\/STS\/AATS\/AHA\/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.","volume":"53","author":"Patel","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R59-5-20210203","first-page":"53","article-title":"Appropriateness of percutaneous coronary intervention.","volume":"306","author":"Chan","year":"2011","journal-title":"JAMA"},{"key":"R60-5-20210203","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCINTERVENTIONS.112.970954","article-title":"Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.","volume":"5","author":"Pursnani","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"R61-5-20210203","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.297.18.1985","article-title":"Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial.","volume":"297","author":"Erne","year":"2007","journal-title":"JAMA"},{"key":"R62-5-20210203","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jacc.2003.08.065","article-title":"The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results.","volume":"43","author":"Hueb","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R63-5-20210203","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/0735-1097(95)00384-3","article-title":"The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses.","volume":"26","author":"Hueb","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R64-5-20210203","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jcin.2008.08.002","article-title":"Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study.","volume":"1","author":"Nishigaki","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"R65-5-20210203","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(97)07298-X","article-title":"Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants.","volume":"350","year":"1997","journal-title":"Lancet"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:49:55Z","timestamp":1620949795000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-201607000-00005"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000085","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}